Skip to main content

Table 3 Optical coherence tomography measurements

From: Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography

  Overall (n = 60) DM (n = 37) Non-DM (n = 23) P value (DM vs. non-DM)
OCT follow-up duration (days) 277 ± 69 287 ± 77 261 ± 51 0.16
Mean stent area (mm2) 6.7 ± 1.9 6.3 ± 1.8 7.2 ± 1.9 0.063
Mean minimum stent area (mm2) 5.3 ± 1.8 5.0 ± 1.7 5.8 ± 1.7 0.073
Mean SEI 0.89 ± 0.03 0.90 ± 0.03 0.88 ± 0.02 0.060
Average of minimum SEI 0.79 ± 0.07 0.79 ± 0.07 0.78 ± 0.06 0.52
Mean lumen area (mm2) 6.1 ± 1.9 5.7 ± 1.77 6.7 ± 1.9 0.051
Mean number of struts 271 ± 112 292 ± 124 237 ± 83 0.070
Mean number of uncovered struts 2.2 ± 2.9 2.4 ± 3.2 1.9 ± 2.2 0.47
Frequency of uncovered struts (%) 0.78 0.79 0.78 0.97
Mean neointimal thickness (µm) 82 ± 35 86 ± 36 75 ± 33 0.28
Mean neointima area (mm2) 0.63 ± 0.31 0.65 ± 0.29 0.61 ± 0.35 0.60
Average of max neointimal thickness (µm) 350 ± 180 420 ± 180 380 ± 150 0.44
Variability in neointima thickness 67 ± 26 73 ± 29 59 ± 18 0.060
Frequency of stent with in-stent thrombi 5 (8.3) 5 (13.5) 0 (0.0) 0.080
  1. Values are mean ± standard deviation or number (%)
  2. OCT optical coherence tomography, SEI stent eccentricity index